Omega Healthcare Investors, Inc. (NYSE:OHI) Receives $43.38 Average Target Price from Analysts

Key Points

• Omega Healthcare Investors, Inc. has received a consensus rating of "Moderate Buy" from analysts, with an average 12-month price target of $43.3750.
• In the most recent quarter, the company reported $0.77 earnings per share, significantly beating analysts' estimates and reflecting an 11.8% increase in revenue year-over-year.
• The firm recently declared a quarterly dividend of $0.67, resulting in an annualized dividend yield of 6.3%, despite a high dividend payout ratio of 165.43%.

Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report) has received an average rating of "Moderate Buy" from the ten ratings firms that are covering the company, Marketbeat reports. Five research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target among brokers that have covered the stock in the last year is $43.3750.

Several research firms have recently commented on OHI. Scotiabank lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 28th. Royal Bank Of Canada lifted their price target on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a research report on Thursday, August 7th. Truist Financial increased their price objective on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a report on Wednesday, September 3rd. Wells Fargo & Company lifted their target price on Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, August 27th. Finally, Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd.

Omega Healthcare Investors Stock Down 0.0%

OHI traded down $0.00 during trading on Friday, hitting $42.83. The stock had a trading volume of 1,845,742 shares, compared to its average volume of 1,847,123. The stock has a 50 day simple moving average of $40.02 and a two-hundred day simple moving average of $38.15. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. Omega Healthcare Investors has a twelve month low of $35.04 and a twelve month high of $44.42. The company has a market capitalization of $12.63 billion, a PE ratio of 26.44, a PEG ratio of 2.24 and a beta of 0.71.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. The business had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company's revenue was up 11.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts predict that Omega Healthcare Investors will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.3%. Omega Healthcare Investors's payout ratio is currently 165.43%.

Insider Activity at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the sale, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Omega Healthcare Investors

Hedge funds have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd purchased a new position in Omega Healthcare Investors during the second quarter worth approximately $26,000. NBC Securities Inc. acquired a new position in Omega Healthcare Investors in the 1st quarter valued at about $29,000. Smartleaf Asset Management LLC raised its stake in shares of Omega Healthcare Investors by 40.9% in the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust's stock valued at $34,000 after acquiring an additional 268 shares in the last quarter. CENTRAL TRUST Co grew its position in shares of Omega Healthcare Investors by 1,654.4% during the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust's stock worth $37,000 after buying an additional 943 shares in the last quarter. Finally, Bayforest Capital Ltd lifted its position in shares of Omega Healthcare Investors by 395.2% during the 2nd quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust's stock worth $41,000 after purchasing an additional 901 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company's stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.